Wayne Tsuji
Amgen (United States)(US)
Publications by Year
Research Areas
Rheumatoid Arthritis Research and Therapies, Spondyloarthritis Studies and Treatments, Autoimmune and Inflammatory Disorders Research, T-cell and B-cell Immunology, Osteoarthritis Treatment and Mechanisms
Most-Cited Works
- → Etanercept treatment of psoriatic arthritis: Safety, efficacy, and effect on disease progression(2004)884 cited
- → Recombinant human tumor necrosis factor receptor (etanercept) for treating ankylosing spondylitis: A randomized, controlled trial(2003)763 cited
- → Denosumab treatment effects on structural damage, bone mineral density, and bone turnover in rheumatoid arthritis: A twelve‐month, multicenter, randomized, double‐blind, placebo‐controlled, phase II clinical trial(2008)566 cited
- → Radiographic progression of ankylosing spondylitis after up to two years of treatment with etanercept(2008)550 cited
- → OARSI-FDA initiative: defining the disease state of osteoarthritis(2011)379 cited
- → Bone erosions and bone marrow edema as defined by magnetic resonance imaging reflect true bone marrow inflammation in rheumatoid arthritis(2007)268 cited
- Continued inhibition of radiographic progression in patients with psoriatic arthritis following 2 years of treatment with etanercept.(2006)
- → Effects of denosumab on bone mineral density and bone turnover in patients with rheumatoid arthritis receiving concurrent glucocorticoids or bisphosphonates(2009)193 cited
- Longterm safety, efficacy, and radiographic outcome with etanercept treatment in patients with early rheumatoid arthritis.(2005)
- → Denosumab‐mediated increase in hand bone mineral density associated with decreased progression of bone erosion in rheumatoid arthritis patients(2010)122 cited